|
|
 |
|
| Topics > Anemia Effects and Management |
|
Topic News Focus
Sep 10, 2010
Reporting by NATAonline staff
Joint ISBT / NATA Session During the XXXIst International Congress of the ISBT Published: May 2010
During the XXXIst International Congress of the ISBT, which will take place in Berlin, Germany, from June 26 to July 1, 2010, a joint ISBT/NATA sesssion will be dedicated to Clinical Hemotherapy.
The joint session is scheduled on Tuesday, June 29 (14:00-15:30), and will feature three presentations by NATA scientific members:
Better Pre-operative Preparation
L. T. Goodnough (USA)
Operative Interventions to Decrease Blood Loss
D. Thomas (UK)
Pharmacological Interventions
M. Samama (France)
Please click on the link above for more information about the ISBT International Congress.
Patterns of Use and Risks Associated With Erythropoiesis-Stimulating Agents Among Medicare Patients Published: Nov 2009
In an article published online on November 10 by the Journal of the National Cancer Institute, Hershman et al. report a large retrospective study in which they used data from Surveillance, Epidemiology, and End Results–Medicare database to assess erythropoiesis-stimulating agent (ESA) usage, blood transfusion, venous thromboembolism (VTE) and overall survival in patients aged 65 years or older diagnosed with colon, non-small cell lung, or breast cancer or with diffuse large B-cell lymphoma between 1991 and 2002, and who received chemotherapy. Among 56,210 patients meeting these criteria, 27% received ESAs (the proportion of patients receiving ESAs increased from 4.8% in 1991 to 45.9% in 2002). The rate of blood transfusion per year remained constant at 22%. VTE developed 14.3% patients who received ESAs and in 9.8% of those who did not(hazard ratio, 1.93; 95% CI, 1.79-2.07). Overall survival was similar in both groups. The authors conclude that "further efforts at monitoring use and long-term toxicity of expensive oncology drugs should be put in place to ensure that for any drug the benefits outweigh the risks in community practice."
New Guidelines: Diagnosis and Management of Iron Deficiency and Anemia in IBD Published: Oct 2007
New guidelines on Diagnosis and Management of Iron Deficiency and Anemia in Inflammatory Bowel Diseases will be presented on October 29 during the 15th United European Gastroenterology Week. The session, chaired by Prof. Christoph Gasche, will feature presentations on the prevalence and impact of anemia and iron deficiency in IBD (S. Kulnigg, Austria), lessons learned from animal models (B. Oldenburg, the Netherlands), anemia evaluation (A. Dignass, Germany), triggers and targets of anemia therapy (D. Rampton, UK), and treatment of iron deficiency and anemia (G. Van Assche, Belgium). These new guidelines will also be presented by Prof. Gasche during the 9th Annual NATA Symposium in Lisbon.
 See all news items |
|
|
|
|
From the Literature
this week
Sep 10 to 17, 2010
Muñoz M, Ariza D, Gómez-Ramírez S, et al.
Published: Jun 2010
Preoperative anemia in elective cardiac surgery: prevalence, risk factors, and influence on postoperative outcome.
Transfus Alternat Transfus Med 2010;11(2):47-56.
  
 This retrospective observational single-center study confirms a high prevalence of preoperative anemia (36.5%) in patients ...
Lu M, Cohen MH, Rieves D, Pazdur R
Published: May 2010
FDA report: Ferumoxytol for intravenous iron therapy in adult patients with chronic kidney disease.
Am J Hematol 2010;85(5):315-319.
It is well known that intravenous iron offers an effective, feasible route towards reducing the heavy burden of iron-deficiency ...
Reviewed by:S. A. Kozek-Langenecker
Fernandez R, Tubau I, Masip J, Muñoz L, Roig I, Artigas A
Published: May 2010
Low reticulocyte hemoglobin content is associated with a higher blood transfusion rate in critically ill patients: a cohort study.
Anesthesiology 2010;112(5):1211-1215.
This pilot study reports the association between the admission value of the reticulocyte hemoglobin content and red blood ...
Reviewed by:M. Muñoz
See
archives for this topic |
|
|
|
|
|
TATM Journal
